Exosomes and breast cancer angiogenesis; Highlights in intercellular communication

Area of Science:

• Oncology
• Cell Biology
• Biochemistry

Background:

• Breast cancer (BC) is a leading cause of cancer-related mortality in women, characterized by significant cellular and molecular heterogeneity impacting treatment efficacy.
• Tumor angiogenesis, the formation of new blood vessels, is crucial for BC growth, expansion, and metastasis.
• Extracellular vesicles (EVs), particularly exosomes (Exos), are increasingly recognized for their role in intercellular communication within the tumor microenvironment.

Purpose of the Study:

• To elucidate the mechanisms by which breast cancer cells utilize exosomes to modulate angiogenesis.
• To understand the dual pro-angiogenic and anti-angiogenic roles of exosomes in breast cancer.
• To identify potential exosome-based biomarkers and therapeutic strategies for breast cancer treatment.

Main Methods:

• Review and synthesis of current scientific literature on exosome-mediated angiogenesis in breast cancer.
• Detailed discussion of the molecular mediators and cellular interactions involved in exosome biogenesis and cargo sorting.
• Analysis of exosome uptake mechanisms and their impact on recipient endothelial and cancer cells.

Main Results:

• Exosomes derived from breast cancer cells carry diverse molecules (proteins, lipids, nucleic acids) that can promote or inhibit angiogenesis.
• Specific exosomal contents can influence endothelial cell proliferation, migration, and tube formation, key steps in angiogenesis.
• The heterogeneity of exosomal cargo contributes to the variable roles of exosomes in breast cancer progression.

Conclusions:

• Exosomes are critical mediators orchestrating angiogenesis in breast cancer through the transfer of signaling molecules.
• Targeting exosome-mediated pathways presents a promising avenue for developing novel anti-cancer therapies and diagnostic tools.
• Further research into the precise functions of exosomal components is essential for optimizing oncostatic strategies against breast cancer.